The LDL Study

The study drug is a potential new treatment that is hoped to reduce LDL-C (Low-Density Lipoprotein Cholesterol). LDL-C is a lipid that’s also known as the “bad cholesterol.” Elevated levels of LDL-C are a known risk factor for cardiovascular disease.

A type of cholesterol-lowering drug called statins has become the cornerstone treatment for cardiovascular disease, but there is still a significant need for additional treatment options for patients who don’t respond well to statins or who are intolerant to statins due to side effects.

You can participate if you don't know your cholesterol levels - this is tested during the screening process.